Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for China Pharma Holdings (CPHI) over the last 13 years, with Q3 2025 value amounting to $75627.0.

  • China Pharma Holdings' Prepaid Assets fell 3377.79% to $75627.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $75627.0, marking a year-over-year decrease of 3377.79%. This contributed to the annual value of $81328.0 for FY2024, which is 2623.85% down from last year.
  • Latest data reveals that China Pharma Holdings reported Prepaid Assets of $75627.0 as of Q3 2025, which was down 3377.79% from $74869.0 recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Prepaid Assets registered a high of $268498.0 during Q3 2023, and its lowest value of $54034.0 during Q2 2021.
  • Moreover, its 5-year median value for Prepaid Assets was $82469.0 (2025), whereas its average is $101492.2.
  • Per our database at Business Quant, China Pharma Holdings' Prepaid Assets plummeted by 8640.22% in 2021 and then soared by 20766.71% in 2023.
  • Over the past 5 years, China Pharma Holdings' Prepaid Assets (Quarter) stood at $58792.0 in 2021, then skyrocketed by 32.16% to $77697.0 in 2022, then skyrocketed by 41.91% to $110258.0 in 2023, then decreased by 26.24% to $81328.0 in 2024, then fell by 7.01% to $75627.0 in 2025.
  • Its last three reported values are $75627.0 in Q3 2025, $74869.0 for Q2 2025, and $82469.0 during Q1 2025.